Cited by 89Sarcoidosis and Beryllium Toxicity ResearchTuberculosis Research and EpidemiologyInflammatory Biomarkers in Disease Prognosis

Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis

Open access
Iliaz, Sinem, Iliaz, Raim, Ortakoylu, Gonenc, Bahadir, Ayse, Bagci, BelmaAkbaba, Caglar, Emel·2014·Annals of Thoracic Medicine

Abstract

INTRODUCTION: The differential diagnosis of sarcoidosis creates a challange due to tuberculosis also having lung and lymph node involvement. Because both diseases show granulomatous inflammation, it may not be possible to distinguish tuberculosis and sarcoidosis in pathological specimens. As a result of the complexity in the differential diagnosis of sarcoidosis and tuberculosis, new markers for differentiation are being investigated. OBJECTIVE: The aim of our study is to investigate the value of neutrophil/lymphocyte ratio (NLR) as a possible marker in differentiating sarcoidosis and tuberculosis. MATERIALS AND METHODS: In our study, 51 acid-fast bacilli (AFB) positive and/or culture-positive patients with pulmonary tuberculosis, ​​40 patients with biopsy-proven sarcoidosis and a control group consisting of 43 patients were included. In our study, information was collected retrospectively based on hospital records. RESULTS: Leukocyte and neutrophil counts, NLR, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) were significantly higher, and albumin was significantly lower in the tuberculosis group compared with sarcoidosis (for all parameters P < 0.001). The most appropriate cut-off value of NLR to distinguish tuberculosis from sarcoidosis was determined as 2.55. For this cut-off value of NLR there was 79% sensitivity, 69% specificity, 73% positive predictive value (PPV), 75% negative predictive value (NPV), and area under the curve (AUC) was 0.788. For differentiation of sarcoidosis from tuberculosis, accuracy of the NLR test according to this cut-off value was found as 76%. CONCLUSION: NLR as a little known marker in respiratory medicine was found to be supportive in differentiation of tuberculosis and sarcoidosis. More studies on this issue is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/1817-1737.140135

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are significantly higher in TB compared to sarcoidosis, providing a non-invasive diagnostic aid.

    “The neutrophil to lymphocyte ratio and platelet to lymphocyte ratio have been investigated as potential biomarkers. These markers are significantly higher in TB compared to sarcoidosis, providing a non-invasive diagnostic aid [58].”

    From Head and Neck Tuberculosis: A Rare Diagnosis and the Role of Surgical Biopsy and Histopathological Evaluation in Extrapulmonary Disease (2025) · cites this paper as [58]

    The Discussion (page unavailable) reports that an NLR cutoff of 2.55 distinguished tuberculosis from sarcoidosis with 76% accuracy, supporting its potential as a diagnostic aid. Our copy does not report a platelet-to-lymphocyte ratio finding for these groups, and the passages do not establish that NLR was significantly higher in tuberculosis than in sarcoidosis; the stated significant elevations compare each group with controls. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iliaz, S., Iliaz, R., Ortakoylu, G., Bahadir, A., Bagci, B., & Caglar, E.
Venue
Annals of Thoracic Medicine
Published
2014
Volume
9
Issue
4
Pages
232
ISSN
1817-1737 (ISSN-L)
OpenAlex
W2043714428
Cited by
89
References
20
Citations by year
2026: 1 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 4 · 2021: 11 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 7 · 2015: 8
FWCI
5.32
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Annals of Thoracic Medicine (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Physiology › Sarcoidosis and Beryllium Toxicity Research
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
neutrophil-to-lymphocyte ratio, sarcoidosis, pulmonary tuberculosis, differential diagnosis, granulomatous inflammation, inflammatory markers, cut-off values, diagnostic accuracy, erythrocyte sedimentation rate, C-reactive protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review